$0.359600
-0.02-4.16%
Pre-Market: 4:05 AM EDT
Comments
Loading...
Cyclacel Pharmaceuticals (CYCC) Forecast
NewsEarningsCyclacel Pharmaceuticals (CYCC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCyclacel Pharmaceuticals (NASDAQ:CYCC) Stock Quotes, Forecast and News Summary
Cyclacel Pharmaceuticals Stock (NASDAQ: CYCC) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cyclacel Pharmaceuticals (CYCC) stock?
You can purchase shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC) through any online brokerage.
Who are Cyclacel Pharmaceuticals (CYCC) competitors?
Other companies in Cyclacel Pharmaceuticals’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Qualigen Therapeutics (NASDAQ:QLGN) and Molecular Templates (NASDAQ:MTEM).
What is the forecast, or price target, for Cyclacel Pharmaceuticals (CYCC) stock?
Cyclacel Pharmaceuticals has a consensus price target of $9.50.
What is the current price for Cyclacel Pharmaceuticals (CYCC)?
The stock price for Cyclacel Pharmaceuticals (NASDAQ: CYCC) is $0.3596 last updated November 21, 2024 at 4:05 AM EST.
Does Cyclacel Pharmaceuticals (CYCC) pay a dividend?
There are no upcoming dividends for Cyclacel Pharmaceuticals.
When is Cyclacel Pharmaceuticals (NASDAQ:CYCC) reporting earnings?
Cyclacel Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Cyclacel Pharmaceuticals (CYCC) going to split?
There is no upcoming split for Cyclacel Pharmaceuticals.
What sector and industry does Cyclacel Pharmaceuticals (CYCC) operate in?
Cyclacel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.